Gabriel Davi Marena
Universidade de São Paulo, Hospital Universitari i Politècnic La Fe, Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Araraquara
Research areas: Medicine · Infectious Diseases · Antifungal resistance and susceptibility · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems
About
Biomedical, Master in Biotechnology in Regenerative Medicine and Medicinal Chemistry and PhD candidate in Pharmaceutical Sciences at UNESP, Araraquara campus - SP. My work is to develop new nanotechnological systems loaded with drugs for application in infectious diseases.
Employment
Employment history is unavailable.
Education
-
Universidade de São Paulo Pós-Doutorado2024 - Present
- 2022 - 2023
-
Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Araraquara Doutorando2019 - 2023
Projects & Funding
-
Nanotherapy for the control of transmission and systemic infection by Candida auris: in vitro and in vivo studies. Fundação de Amparo à Pesquisa do Estado de São Paulo2024 - 2026
-
Avaliação antifúngica da anfotericina B e micafungina co-encapsuladas em nanoemulsão contra isolados clínicos de Candida auris FAPESP2022 - 2023
-
Microemulsões para co-encapsulação de anfotericina B e micafungina: desenvolvimento, caracterização e avaliação do potencial in vitro e in vivo contra Candida auris FAPESP2019 - 2023
Publications (36)
- Peptide-Pulsed Dendritic Cell Vaccination Confers Protection Response Against Paracoccidioides lutzii in an Experimental Model Save
- Liposomes loaded with Cymbopogon nardus L. Rendle essential oil: Characterization and potential in vitro and in vivo action against Candidozyma auris Save
- The Four Critical Priority Fungi According to the World Health Organization and the Hope for New Therapies: A Focus on Cell Wall Antifungal Targets Save
- A Silver (I) Complex-Loaded Lipid Nanoemulsion: A New Approach Against Candida albicans Biofilms Save
- Improving antifungal lipid-based drug delivery against Candida : a review Save
- Galleria mellonella as an Invertebrate Model for Studying Fungal Infections Save
- Candidozyma auris Alert in South America: An Epidemiological and Therapeutic Update Save
- Amphotericin B and micafungin duo-loaded nanoemulsion as a potential strategy against Candida auris biofilms Save
- Sunflower Oil and Cholesterol Nanoemulsion: A Novel Carrier for Micafungin to Combat Multi-Resistant Candida auris Save
- Engineering resveratrol-loaded chitosan nanoparticles for potential use against Helicobacter pylori infection Save
- Potential Activity of Micafungin and Amphotericin B Co-Encapsulated in Nanoemulsion against Systemic Candida auris Infection in a Mice Model Save
- Development and characterization of potential larvicidal nanoemulsions against Aedes aegypti Save
- A new hydrogel containing a proanthocyanidin polymer-rich extract of Commiphora leptophloeos for treating vulvovaginal candidiasis: Preclinical results using the alternative model of Galleria mellonella Save
- Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four Candida auris Clades: In Vitro and In Vivo Assays Save
- Design of Rapamycin and Resveratrol Coloaded Liposomal Formulation for Breast Cancer Therapy Save
- Anti-Candida auris activity in vitro and in vivo of micafungin loaded nanoemulsions Save
- Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis? Save
- Infection caused by Candida auris: state of the art Save
- Development and characterization of an amphotericin B - loaded nanoemulsion applied to Candida auris biofilms control Save
- Cetyltrimethylammonium bromide in the synthesis of mesoporous silica nanoparticles: General aspects and in vitro toxicity. Save